Waiting for the right prescription

CORPORATE PROFILE

The merger of Swedish firm Astra and the UK’s Zeneca in April 1999 formed one of the world’s largest pharmaceutical companies. FX Week caught up with the firm’s treasury IT manager at the heart of AstraZeneca’s activities in London to find out how the firm views its e-FX options

AstraZeneca is typical of the large multinationals that multi-bank FX portals are targeting for business -- it has a global operation in which foreign exchange and treasury are vital components, and is yet to start e

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact customer services - www.fx-markets.com/static/contact-us, or view our subscription options here: https://subscriptions.fx-markets.com/subscribe

You are currently unable to copy this content. Please contact info@fx-markets.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to FX Markets? View our subscription options

You need to sign in to use this feature. If you don’t have a FX Markets account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: